COVID-19 pandemic response
We continue to follow Government and University of Cambridge guidelines for staying COVID-safe. Our buildings are open for lab-based research work.
About us
The Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories (IMS-MRL) and its embedded MRC Metabolic Diseases Unit investigate the mechanisms through which metabolic health is maintained and how this is disturbed in disease.
We seek to use that knowledge to aid better treatment and prevention of obesity, Type 2 diabetes and related endocrine and metabolic diseases.
IMS-MRL groups encompass skills in genetics, cell biology, cell signalling, neuroendocrinology, bioenergetics, human and animal physiology, experimental medicine and clinical trials.
The IMS-MRL is the base for the MRC Metabolic Diseases Unit which supports four programmes of research that aim to improve understanding of the mechanisms responsible for obesity and related metabolic diseases.
Together with a Welcome Strategic Award, it also supports core scientific facilities that underpin basic and experimental science at the IMS-MRL.
Videos
New Online Event
Innovations in phenotyping for Obesity, Diabetes and Co-morbidities. 6 July 2021
News
Fiona Gribble to give The Physiological Society’s Michael de Burgh Prize Lecture
Congratulations to Professor Fiona Gribble, Deputy Director of the IMS-MRL and Director of Graduate Education for the Cambridge University School of Clinical Medicine, who…
Continue Reading Fiona Gribble to give The Physiological Society’s Michael de Burgh Prize Lecture
Scientists can predict which women will have serious pregnancy complications
Research published today in Nature Communications Biology shows how women who will develop potentially life-threatening disorders during pregnancy can be identified early when hormone levels…
Continue Reading Scientists can predict which women will have serious pregnancy complications
Many of us could carry up to 30 extra pounds of fat due to a change in a single gene
New research published today in Nature Medicine has found that one in every 340 people might carry a mutation in a single gene that…
Maša Josipović wins Bill Gates Senior Prize
Congratulations to Maša Josipović, PhD student from Mark Evans’ group, who is the joint recipient of the 2021 Bill Gates Senior Prize. The award,…
Continue Reading Maša Josipović wins Bill Gates Senior Prize
